I agree that this site is using cookies. You can find further informations here.
X
Cortot, Alexis B.
193  results:
Search for persons X
?
1

PPD01.01 ctDNA Dynamics, Prognostic Markers and Resistance ..:

Le, Xiuning ; Garassino, Marina Chiara ; Ahn, Myung-Ju...
Journal of Thoracic Oncology.  19 (2024)  7 - p. e4 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Faecalibacterium prausnitziistrain EXL01 boosts efficacy of..:

Bredon, Marius ; Danne, Camille ; Pham, Hang Phuong...
OncoImmunology.  13 (2024)  1 - p. , 2024
Link: https://doi.org/10.1080/..
 
?
3

MET Exon 14 Skipping in NSCLC: A Systematic Literature Revi..:

Mazieres, Julien ; Vioix, Helene ; Pfeiffer, Boris M....
Clinical Lung Cancer.  24 (2023)  6 - p. 483-497 , 2023
Link: https://doi.org/10.1016/..
 
?
4

Histo-Molecular Factors of Response to Combined Chemotherap..:

Marchal, Marine ; Leroy, Vincent ; Behal, Hélène...
Targeted Oncology.  18 (2023)  6 - p. 927-939 , 2023
Link: https://doi.org/10.1007/..
 
?
5

Characterization of 164 patients with NRAS mutated non-smal..:

Dehem, Agathe ; Mazieres, Julien ; Chour, Ali...
Lung Cancer.  186 (2023)  - p. 107393 , 2023
Link: https://doi.org/10.1016/..
 
?
6

Transforming properties of MET receptor exon 14 skipping ca..:

Fernandes, Marie ; Paget, Sonia ; Kherrouche, Zoulika...
FEBS Letters.  597 (2023)  18 - p. 2301-2315 , 2023
Link: https://doi.org/10.1002/..
 
?
7

MET exon 14 skipping mutation is a hepatocyte growth factor..:

Fernandes, Marie ; Hoggard, Brynna ; Jamme, Philippe...
Molecular Oncology.  17 (2023)  11 - p. 2257-2274 , 2023
Link: https://doi.org/10.1002/..
 
?
8

Response to Capmatinib in a MET Fusion-positive Cholangioca..:

Turpin, Anthony ; Descarpentries, Clotilde ; Grégoire, Valérie...
The Oncologist.  28 (2023)  1 - p. 80-83 , 2023
Link: https://doi.org/10.1093/..
 
?
9

Brief Report: First-line Pembrolizumab in Metastatic Non-Sm..:

Guisier, Florian ; Descourt, Renaud ; Babey, Helene...
Clinical Lung Cancer.  23 (2022)  8 - p. e545-e549 , 2022
Link: https://doi.org/10.1016/..
 
?
10

A Case Report of Successful Treatment With Crizotinib to Ov..:

Pinquie, François ; Cortot, Alexis B. ; Chevalier, Louise-Marie...
Clinical Lung Cancer.  23 (2022)  2 - p. e131-e134 , 2022
Link: https://doi.org/10.1016/..
 
?
11

Tepotinib Efficacy and Safety in Patients with MET Exon 14 ..:

Le, Xiuning ; Sakai, Hiroshi ; Felip, Enriqueta...
Clinical Cancer Research.  28 (2022)  6 - p. 1117-1126 , 2022
Link: https://doi.org/10.1158/..
 
?
12

Lorlatinib for advanced anaplastic lymphoma kinase–positive..:

Baldacci, Simon ; Besse, Benjamin ; Avrillon, Virginie...
European Journal of Cancer.  166 (2022)  - p. 51-59 , 2022
Link: https://doi.org/10.1016/..
 
?
13

Safety of Tepotinib in Patients With MET Exon 14 Skipping N..:

Veillon, Remi ; Sakai, Hiroshi ; Le, Xiuning...
Clinical Lung Cancer.  23 (2022)  4 - p. 320-332 , 2022
Link: https://doi.org/10.1016/..
 
?
14

Paclitaxel–bevacizumab combination in advanced non-squamous..:

Bilger, Geoffroy ; Toffart, Anne-Claire ; Darrason, Marie...
Therapeutic Advances in Medical Oncology.  14 (2022)  - p. 175883592210993 , 2022
Link: https://doi.org/10.1177/..
 
?
15

When the MET receptor kicks in to resist targeted therapies:

Fernandes, Marie ; Jamme, Philippe ; Cortot, Alexis B...
Oncogene.  40 (2021)  24 - p. 4061-4078 , 2021
Link: https://doi.org/10.1038/..
 
1-15